Sort
48,018 grants matching “immunotherapy”
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$366,000Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2020 · CA
Role of KMT2D and aberrant enhancers in modulating tumor microenvironment in melanoma
$366,000Kunal Rai · University Of Tx Md Anderson Can Ctr · R01 · FY2018 · CA
The molecular and immune evolution in the progression of lung neoplasia to invasive adenocarcinoma
$366,000Jianjun Zhang · University Of Tx Md Anderson Can Ctr · R01 · FY2019 · CA
The Role of Epithelial-Mesenchymal Transition in Re-Wiring KRAS Mutant Lung Cancer
$366,000Don Lynn Gibbons · University Of Tx Md Anderson Can Ctr · R37 · FY2022 · CA
Fgl-2 targeted therapy for reversing multi-modality immune suppression
$366,000Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2016 · CA
Fgl-2 targeted therapy for reversing multi-modality immune suppression
$366,000Shulin Li · University Of Tx Md Anderson Can Ctr · R01 · FY2020 · CA
CD8 Tcells and Tissue E-cadherin in Host Defense Against Oral Candidiasis in HIV
$365,957Paul L Fidel · Lsu Health Sciences Center · R56 · FY2012 · DE
Examining the role of the miR-181a:Wnt/B-catenin axis in ovarian cancer
$365,943Analisa Virginia Difeo · University Of Michigan At Ann Arbor · R01 · FY2023 · CA
Genetic Approaches to Enhance the Anti-Tumor Functions of T Lymphocytes
$365,930Michel Sadelain · Sloan-Kettering Inst Can Research · P01 · FY2009 · CA
Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies
$365,919William Joseph Murphy · University Of California At Davis · R01 · FY2017 · CA
Radio-immunotherapy to Target Cancer Stem Cells in Solid Tumor Malignancies
$365,919William Joseph Murphy · University Of California At Davis · R01 · FY2018 · CA
Protein Structure/Function by NMR, Crystallography and Computational Chemistry
$365,896Eric Oldfield · University Of Illinois At Urbana-Champaign · R01 · FY2009 · AI
Local Immunoregulation of Carcinogenesis
$365,894Michael Girardi · Yale University · R01 · FY2010 · CA
Project 3: The Functional Contribution of Tumor Immunity in PDAC
$365,868Raghu Kalluri · University Of Tx Md Anderson Can Ctr · P01 · FY2016 · CA
Scientific Core B
$365,826Holden T. Maecker · Stanford University · U19 · FY2016 · AI
Arming Neutrophils for the Destruction of HIV by Anti-HIV Antibody
$365,802Lisa A. Cavacini · Beth Israel Deaconess Medical Center · R01 · FY2008 · AI
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases
$365,771Ajay V. Maker · University Of Illinois At Chicago · R37 · FY2020 · CA
Stimulating Lymphocyte Activation Combined with Inhibition of Immunosuppressive Signals in Colon Cancer Metastases
$365,771Ajay V. Maker · University Of Illinois At Chicago · R37 · FY2021 · CA
Genetics and Immune Predictors for Recurrent Glomerular Diseases in the Kidney Allograft
$365,766Ibrahim Batal · Columbia University Health Sciences · R01 · FY2025 · DK
Immunotherapeutic Modalities for K-ras Mutant Lung Cancer: Sex- and Cell Type-Specific Roles of IL-6/STAT3 signaling
$365,756Seyed Javad Mirhassani Moghaddam · University Of Tx Md Anderson Can Ctr · R01 · FY2021 · CA
Biofilm Formation by Pneumocystis
$365,754Melanie T Cushion · University Of Cincinnati · R01 · FY2008 · AI
OSTEOCLASTS AND BONE CANCER
$365,752University Of Minnesota Twin Cities · R01 · FY2001 · AR
DC exosome therapy to resolve inflammatory bone loss and oral infection
$365,750Christopher W Cutler · Augusta University · R01 · FY2021 · DE
DC exosome therapy to resolve inflammatory bone loss and oral infection
$365,750Ranya Elsayed · Augusta University · R01 · FY2025 · DE
Studying the initiation, progression and therapy of lung cancer in mouse models
$365,750Martin McMahon · University Of Utah · R01 · FY2024 · CA